Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Satı Coşkun Yazgan"'
Autor:
Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract This study aims to investigate the prognostic value of the systemic immune-inflammation index (SII)and its impact on survival in patients with metastatic renal cell carcinoma (mRCC). A total of 706patients with mRCC treated with tyrosine kin
Externí odkaz:
https://doaj.org/article/ff731989e9c14a97850334af8794a507
Autor:
Cihan Erol, Emre Yekedüz, Deniz Tural, Serdar Karakaya, Nihan Şentürk Öztaş, Gökhan Uçar, Saadettin Kılıçkap, İsmail Ertürk, Özlem Nuray Sever, Çağatay Arslan, Ahmet Küçükarda, Orçun Can, Özlem Balvan, Satı Coşkun Yazgan, Mustafa Özgüroğlu, Berna Öksüzoğlu, Mehmet Ali Nahit Şendur, Yüksel Ürün
Publikováno v:
Urologia Internationalis. :1-7
Introduction: We aimed to evaluate clinical features, prognostic factors, and treatment preferences in patients with non-clear cell renal cell carcinoma (nccRCC). Methods: Patients with metastatic nccRCC were selected from the Turkish Oncology Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bf0bfca5db9383fcb30bc0a60930218
https://doi.org/10.1159/000528994
https://doi.org/10.1159/000528994
Publikováno v:
The Prostate. 82:1456-1461
To assess the prognostic effect of pan-immune inflammation value (PIV) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) or enzalutamide.Patients with mCRPC treated with AA or enzalutamide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cddcca380235749df2938d4af9f26ab2
https://doi.org/10.1002/pros.24419
https://doi.org/10.1002/pros.24419
Autor:
eda eylemer mocan, eda Eylemer Mocan, Emre Yekedüz, Göktürk Karataş, Satı Coşkun Yazgan, Elif Berna Köksoy, Filiz Çay Şenler, Güngör Utkan, Ahmet Demirkazık, Hakan Akbulut, Yüksel Ürün
Background Histamine and H1 receptor play a crucial role in the tumor microenvironment. Preclinical data showed that concomitant use of antihistamines and immune checkpoint inhibitors (ICIs) may increase the effect of ICIs. This study aimed to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bcf4f1da5dd88955e5557149230986a
https://doi.org/10.21203/rs.3.rs-1733647/v1
https://doi.org/10.21203/rs.3.rs-1733647/v1
